Tenex Health (Lake Forest, CA) landed FDA clearance for its new TX2 MicroTip ultrasonic device for removal of soft tissue when treating tendinosis of the shoulder or hip. Percutaneous tenotomies can be performed in an outpatient setting with the device, which is a longer version of the TX1 MicroTip.
The original generation of the device has a tip that’s too short for shoulder and hip procedures. The new device has a two inch tip which allows for a wider range of tenotomies to be performed with Tenex’s technology.
“The TX1 MicroTip has enjoyed tremendous clinical success in treating over 35,000 patients in the US since its introduction in 2012,” said Dr. Bernard Morrey, Chief Medical Officer of Tenex Health. “Of these patients, only a small portion have been treated with shoulder or hip tendinosis due to the inaccessibility of the deeper tissues to the TX1 MicroTip. The length and design of the TX2 MicroTip is well poised to effectively treat a large number of patients with a spectrum of conditions in these anatomic areas. We anticipate providing a favorable safety and efficacy profile to a broader group of patients using this ultrasound guided treatment.”
Source: Tenex Health…